Motif Bio PLC Result of GM (5169S)
December 21 2016 - 10:05AM
UK Regulatory
TIDMMTFB
RNS Number : 5169S
Motif Bio PLC
21 December 2016
Motif Bio plc
("Motif Bio" or the "Company")
Result of GM
Motif Bio plc (AIM: MTFB) the clinical stage biopharmaceutical
company specialising in developing novel antibiotics, announces
that all resolutions put to shareholders at the Company's General
Meeting held earlier today were duly passed.
For further information please contact:
Motif Bio plc info@motifbio.com
Graham Lumsden (Chief
Executive Officer)
Zeus Capital Limited
(NOMAD & BROKER) +44 (0)20 3829 5000
Phil Walker/Giles Balleny
Dominic Wilson
Northland Capital Partners
Limited (BROKER) +44 (0)203 861 6625
Patrick Claridge/ David
Hignell
John Howes/ Rob Rees
(Broking)
Walbrook PR Ltd. (FINANCIAL +44 (0) 20 7933 8780 or
PR & IR) motifbio@walbrookpr.com
Paul McManus Mob: +44 (0)7980 541
893
Mike Wort Mob: +44 (0)7900 608
002
MC Services AG (EUROPEAN
IR) +49 (0)89 210 2280
Raimund Gabriel
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROMEFLFLQLFBFBX
(END) Dow Jones Newswires
December 21, 2016 10:05 ET (15:05 GMT)
Motif Bio (LSE:MTFB)
Historical Stock Chart
From Apr 2024 to May 2024
Motif Bio (LSE:MTFB)
Historical Stock Chart
From May 2023 to May 2024